These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 25459104)
21. Examination of the effects of varenicline, bupropion, lorcaserin, or naltrexone on responding for conditioned reinforcement in nicotine-exposed rats. Guy EG; Fisher DC; Higgins GA; Fletcher PJ Behav Pharmacol; 2014 Dec; 25(8):775-83. PubMed ID: 25230208 [TBL] [Abstract][Full Text] [Related]
22. Naltrexone/bupropion for obesity: an investigational combination pharmacotherapy for weight loss. Billes SK; Sinnayah P; Cowley MA Pharmacol Res; 2014 Jun; 84():1-11. PubMed ID: 24754973 [TBL] [Abstract][Full Text] [Related]
23. Naltrexone Maintenance Decreases Cannabis Self-Administration and Subjective Effects in Daily Cannabis Smokers. Haney M; Ramesh D; Glass A; Pavlicova M; Bedi G; Cooper ZD Neuropsychopharmacology; 2015 Oct; 40(11):2489-98. PubMed ID: 25881117 [TBL] [Abstract][Full Text] [Related]
24. Physiological and subjective effects of acute intranasal methamphetamine during extended-release alprazolam maintenance. Lile JA; Stoops WW; Glaser PE; Hays LR; Rush CR Drug Alcohol Depend; 2011 Dec; 119(3):187-93. PubMed ID: 21737214 [TBL] [Abstract][Full Text] [Related]
25. The Effects of Pharmacological Opioid Blockade on Neural Measures of Drug Cue-Reactivity in Humans. Courtney KE; Ghahremani DG; Ray LA Neuropsychopharmacology; 2016 Nov; 41(12):2872-2881. PubMed ID: 27312405 [TBL] [Abstract][Full Text] [Related]
26. A gender-based secondary analysis of the ADAPT-2 combination naltrexone and bupropion treatment for methamphetamine use disorder trial. Levander XA; Carmody T; Cook RR; Potter JS; Trivedi MH; Korthuis PT; Shoptaw S Addiction; 2023 Jul; 118(7):1320-1328. PubMed ID: 36864016 [TBL] [Abstract][Full Text] [Related]
28. Bupropion differentially impacts acquisition of methamphetamine self-administration and sucrose-maintained behavior. Reichel CM; Linkugel JD; Bevins RA Pharmacol Biochem Behav; 2008 May; 89(3):463-72. PubMed ID: 18329085 [TBL] [Abstract][Full Text] [Related]
29. Physiological and subjective effects of acute intranasal methamphetamine during atomoxetine maintenance. Rush CR; Stoops WW; Lile JA; Glaser PE; Hays LR Pharmacol Biochem Behav; 2011 Nov; 100(1):40-7. PubMed ID: 21802442 [TBL] [Abstract][Full Text] [Related]
30. Executive function moderates naltrexone effects on methamphetamine-induced craving and subjective responses. Lim AC; Grodin EN; Green R; Venegas A; Meredith LR; Courtney KE; Moallem NR; Sayegh P; London ED; Ray LA Am J Drug Alcohol Abuse; 2020 Sep; 46(5):565-576. PubMed ID: 32343625 [No Abstract] [Full Text] [Related]
31. Bupropion/naltrexone fixed-dose combination for the treatment of obesity. Halpern B; Faria AM; Halpern A Drugs Today (Barc); 2011 Aug; 47(8):575-81. PubMed ID: 21850280 [TBL] [Abstract][Full Text] [Related]
32. Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving. Newton TF; Roache JD; De La Garza R; Fong T; Wallace CL; Li SH; Elkashef A; Chiang N; Kahn R Neuropsychopharmacology; 2006 Jul; 31(7):1537-44. PubMed ID: 16319910 [TBL] [Abstract][Full Text] [Related]
33. The effects of acute oral naltrexone pretreatment on the abuse potential of intranasal methamphetamine, and the relationship between reward/punishment sensitivity and methamphetamine's effects. Jones JD; Mumtaz M; Vadhan NP; Martinez S; Pramanik S; Manubay J; Mogali S; Perez F; Castillo F; Kranzler HR; Comer SD Behav Pharmacol; 2022 Jun; 33(4):255-265. PubMed ID: 35438671 [TBL] [Abstract][Full Text] [Related]
34. Effects of amylin and bupropion/naltrexone on food intake and body weight are interactive in rodent models. Clapper JR; Athanacio J; Wittmer C; Griffin PS; D'Souza L; Parkes DG; Roth JD Eur J Pharmacol; 2013 Jan; 698(1-3):292-8. PubMed ID: 23178527 [TBL] [Abstract][Full Text] [Related]
35. Interaction between naltrexone and oral THC in heavy marijuana smokers. Haney M; Bisaga A; Foltin RW Psychopharmacology (Berl); 2003 Feb; 166(1):77-85. PubMed ID: 12491025 [TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of naltrexone for amfetamine and methamfetamine use disorder: a systematic review of randomized controlled trials. Lam L; Anand S; Li X; Tse ML; Zhao JX; Chan EW Clin Toxicol (Phila); 2019 Apr; 57(4):225-233. PubMed ID: 30451013 [TBL] [Abstract][Full Text] [Related]
37. Naltrexone + bupropion (Mysimba). Too risky for only modest weight loss. Prescrire Int; 2015 Oct; 24(164):229-33. PubMed ID: 26594724 [TBL] [Abstract][Full Text] [Related]
38. Naltrexone attenuates cue- but not drug-induced methamphetamine seeking: a possible mechanism for the dissociation of primary and secondary reward. Anggadiredja K; Sakimura K; Hiranita T; Yamamoto T Brain Res; 2004 Sep; 1021(2):272-6. PubMed ID: 15342276 [TBL] [Abstract][Full Text] [Related]
39. The effects of bupropion alone and combined with naltrexone on blood pressure and CRP concentration: A systematic review and meta-regression analysis of randomized controlled trials. Jiang Q; Velu P; Sohouli MH; Ziamanesh F; Shojaie S; Fatahi S; Li Q Eur J Clin Invest; 2024 Mar; 54(3):e14118. PubMed ID: 37924302 [TBL] [Abstract][Full Text] [Related]
40. Bupropion and naltrexone combination alters high fructose corn syrup self-administration and gene expression in rats. Levy A; Daniels S; Hudson R; Horman T; Flynn A; Zhou Y; Leri F Neuropharmacology; 2018 Jun; 135():547-554. PubMed ID: 29408463 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]